Complement-mediated neurotoxicity is regulated by homologous restriction
- 1 February 1995
- journal article
- Published by Elsevier in Brain Research
- Vol. 671 (2) , 282-292
- https://doi.org/10.1016/0006-8993(94)01264-i
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Synthetic Alzheimer amyloid β/A4 peptides enhance production of complement C3 component by cultured microglial cellsBrain Research, 1993
- Complement activation and β-amyloid-mediated neurotoxicity in Alzheimer's diseaseResearch in Immunology, 1992
- Complement proteins and complement inhibitors in Alzheimer's diseaseResearch in Immunology, 1992
- Complements, microglial cells and amyloid fibril formationResearch in Immunology, 1992
- Cerebral amyloid plaques in Alzheimer’s disease but not in scrapie-affected mice are closely associated with a local inflammatory processVirchows Archiv B Cell Pathology Including Molecular Pathology, 1991
- The control of homologous lysisImmunology Today, 1991
- Restriction factors of homologous complement: A new candidate?Immunology Today, 1990
- Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.Journal of Clinical Investigation, 1989
- Complement induces a transient increase in membrane permeability in unlysed erythrocytes.Journal of Clinical Investigation, 1988
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982